Trends in past-month cannabis use among US adults across a range of disabilities and health conditions, 2015-2019.
Autor: | Yang KH; University of California San Diego School of Medicine, Department of Psychiatry, 9500 Gilman Drive, San Diego, CA 92093, USA. Electronic address: kevinyang@health.ucsd.edu., Tam RM; University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science, 9500 Gilman Drive, San Diego, CA 92093, USA., Satybaldiyeva N; University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science, 9500 Gilman Drive, San Diego, CA 92093, USA., Kepner W; University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science, 9500 Gilman Drive, San Diego, CA 92093, USA., Han BH; University of California San Diego School of Medicine, Department of Medicine, 9500 Gilman Drive, San Diego, CA 92093, USA., Moore AA; University of California San Diego School of Medicine, Department of Medicine, 9500 Gilman Drive, San Diego, CA 92093, USA., Palamar JJ; NYU Grossman School of Medicine, Department of Population Health, 180 Madison Avenue, New York, NY 10016, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Preventive medicine [Prev Med] 2023 Dec; Vol. 177, pp. 107768. Date of Electronic Publication: 2023 Nov 10. |
DOI: | 10.1016/j.ypmed.2023.107768 |
Abstrakt: | Introduction: While there is increasing interest in the use of cannabis to manage a range of health-related symptoms, little is known about trends in recent cannabis use with respect to various health conditions. Methods: We examined data from a US representative sample of noninstitutionalized adults age ≥ 18 from the 2015-2019 National Survey on Drug Use and Health (N = 214,505). We estimated the pooled prevalences followed by linear time trends, overall, and by disability (i.e., difficulty hearing, seeing, thinking, walking, dressing, doing errands) and lifetime (i.e., bronchitis, cancer, diabetes, hepatitis, kidney disease) and current (i.e., asthma, depression, heart disease, hypertension) health condition status using logistic regression. Models with year-by-condition status interaction terms were used to assess differential time trends, adjusting for demographic characteristics. Results: From 2015 to 2019, cannabis use increased significantly among adults with and without each disability and health condition examined. However, the increase was more rapid among those with (versus without) difficulty hearing (89.8% increase [4.9% to 9.3%] vs. 37.9% increase [8.7% to 12.0%], p = 0.015), difficulty walking (84.1% increase [6.3% to 11.6%] vs. 36.8% increase [8.7% to 11.9%], p < 0.001), 2-3 impairments (75.3% increase [9.3% to 16.3%] vs. 36.6% increase [8.2% to 11.2%], p = 0.041), and kidney disease (135.3% increase [3.4% to 8.0%] vs. 38.4% increase [8.6% to 11.9%], p = 0.045). Conclusion: Given the potential adverse effects of cannabis, prevention and harm reduction efforts should focus on groups at increasingly higher risk for use, including those with disabilities and kidney disease. Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2023 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |